Missed diagnosis of tardive dystonia in an adolescent girl treated with risperidone

Journal of Child and Adolescent Psychopharmacology

Volumn 21, Issue 2, 2011, Pages 191-194

  Pringsheim, Tamara ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLONAZEPAM; LEVODOPA; OLANZAPINE; RISPERIDONE; TRIHEXYPHENIDYL;

ADOLESCENT; ARTICLE; CASE REPORT; COMPULSION; CONVERSION DISORDER; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; DYSTONIA; FEMALE; GAIT DISORDER; HUMAN; MUSCLE TWITCH; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SOCIAL PHOBIA; SUICIDAL IDEATION; TARDIVE DYSTONIA; VOLUNTARY MOVEMENT; WEIGHT REDUCTION;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; DELAYED DIAGNOSIS; FEMALE; HUMANS; MOVEMENT DISORDERS; RISPERIDONE;

EID: 79955163037     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2010.0122     Document Type: Article

References (25)

1. Adityanjee, Esterera AB: Successful treatment of tardive dystonia with clozapine. Biol Psychiatry 39:1064-1065, 1996.
2. American Psychiatic Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
3. Bassitt DP, Neto MRL: Clozapine efficacy in tardive dyskinesia in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 248: 209-211, 1998.
4. Burke RE, Fahn S, Jankovic J, Marsden D, Lang A, Gollomp S, Ilson J: Tardive dystonia: Late onset and persistent dystonia caused by antipsychotic drugs. Neurology 32:1335-1346, 1982.
5. Chatterjee A, Forrest Gordon M, Giladi N, Trosch R: Botulinum toxin in the treatment of tardive dystonia. J Clin Psychopharmacol 17:497-498, 1997.
6. Connor D, McLaughlin T, Jeffers-Terry M: Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder. J Child Adolesc Psychopharmacol 18:140-156, 2008.
7. Conus P, Zullino D, Baumann P: Clozapine is more efficacious for tongue dystonia than olanzapine. Psychopharmacology 162:89, 2002.
8. Correll C, Kane J: One year incidence rates of tardive dyskinesia in children and adolescents treated with second generation antipsychotics: A systematic review. J Child Adolesc Psychopharmacol 17:647-655, 2007.
9. DelBello M, Chang K, Welge J, Adler C, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado S, Strakowski S: A doubleblind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar disord 11:483-493, 2009.
10. DelBello M, Schwiers M, Rosenberg L, Strakowski S: A doubleblind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41:1216-1223, 2002.
11. Dressler D, Oeljeschlager RO, Ruther E: Severe tardive dystonia: Treatment with continuous intrathecal baclofen administration. Mov Disord 12:585-587, 1997.
12. Franzini A, Marras C, Ferroli P, Zorzi G, Bugiani O, Romito L, Broggi C: Long term high frequency bilateral pallidal stimulation for neuroleptic induced tardive dystonia. Report of two cases. J Neurosurgery 102:721-725, 2005.
13. Friedman JH: Clozapine treatment of psychosis in patients with tardive dystonia: Report of three cases. Mov Disord 9:321-324, 1994.
14. Jankovic J, Beach J: Long term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 48:358-362, 1997.
15. Kumra S, Frazier J, Jacobsen L, McKenna K, Gordon C, Lenane M, Hamburder S, Smith A, Albus K, Alaghband-Rad J, Rapoport J: Childhood-onset schizophrenia: A double-blind clozapinehaloperidol comparison. Arch Gen Psychiatry 53:1090-1097, 1996.
16. Kumra S, Kranzler H, Gerbino-Rosen G, Kester H, DeThomas C, Cullen K, Regan J, Kane J: Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: An open-label extension study. J Child Adolesc Psychopharmacol 18:307-316, 2008.
17. Miller D, Caroff S, Davis S, et al.: Extrapyramidal side effects of antipsychotics in a randomized trial. Br J Psychiatry 193:279-288, 2008.
18. Monteiro L: Tardive dyskinesia controlled by anticholinergic agents. Clin Neuropharmacol 8:372-376, 1985.
19. Pringsheim T, Lam D, Ching H, Patten P: Metabolic and neurological complications of second generation antipsychotic use in children: A systematic review and meta-analysis of randomized controlled trials. In press.
20. Rosse RB, Allen A, Lux WE: Baclofen treatment in a patient with tardive dystonia. J Clin Psychiatry 47:474-475, 1986.
21. Sallee F, Kurlan R, Goetz C, Signer H, Scahill L, Law G, Dittman V, Chappell P: Ziprasidone treatment of children and adolescents with tourette syndrome: A pilot study. J Am Acad Child Adolesc Psychiatry 39:292-299, 2000.
22. Shaw P, Sporn A, Gogtay N, Overman G, Greenstein D, Gochman P, Tossell J, Lenane M, Rapoport J: Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison. Arch Gen Psychiatry 63:721-730, 2006.
23. Sikich L, Frazier J, McClellan J, Findling RL, Vitiello B, Ritz L, Ambler D, Puglia M, Maloney AE, Michael E, De Jong S, Slifka K, Noyes N, Hlastala S, Pierson L, McNamara NK, Delporto-Bedoya D, Anderson R, Hamer RM, Lieberman JA: Double-blind comparison of first- and second-generation antipsychotics in early-onsetschizophrenia and schizoaffective disorder: Findings from the Treatment of Early-onset Schizophrenia Spectrum Disorders (TEOSS) Study. Am J Psychiatry 165:1420-1431, 2008.
24. Sikich L, Hamer R, Bashford R, Sheitman BB, Lieberman JA: A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: A double-blind, randomized, 8-week trial. Neuropsychopharmacology 29:133-145, 2004.
25. Wonodi I, Reeves G, Carmichael D, Verovsky I, Avila MT, Elliott A, Hong LE, Adami HM, Thaker GK: Tardive dyskinesia in children treated with atypical antipsychotic medications. Mov Disord 22:1777-1782, 2007.